Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines: Report* from a WHO-UNAIDS consultation 13-15 March 2001, Geneva, Switzerland

AIDS

Volumn 16, Issue 10, 2002, Pages

  Almond, Neil ^a   Anzala, Omu ^a   Bektimirov, Tagir ^a   Berman, Phillip ^a   Birx, Deborah ^a   Carvalheiro, José ^a   Chongprasert, Suchart ^a   Cichutek, Klaus ^a   Darbyshire, Janet ^a   Duarte, Carlos ^a   Ensoli, Barbara ^a   Fenyo, Eva Maria ^a   Girard, Marc ^a   Goldenthal, Karen ^a   Golding, Hana ^a   Holmes, Harvey ^a   Johnston, Margaret ^a   Mallet, Laurent ^a   Mawle, Alison ^a   Mugerwa, Roy ^a   Pitisuttithum, Punnee ^a   Rees, Helen ^a   Robertson, James ^a   Rowland Jones, Sarah ^a   Sang, Guowei ^a   Schild, Geoffrey ^a   Shao, Yiming ^a   Sheets, Rebecca ^a   Takemori, Toshitada ^a   Tramont, Edmund ^a   Vandepapeliere, Pierre ^a   Van der Groen, Guido ^a   Weiner, David ^a   Widdus, Roy ^a   Esparza, Jose ^a   Griffiths, Elwyn ^a   Knezevic, Ivana ^a   Milstien, Julie ^a   Osmanov, Saladin ^a   Susuki, Yasuhiro ^a   Wood, David ^a   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Clinical trials; HIV AIDS vaccines; Product development; Regulatory requirements

Indexed keywords

BCG VACCINE; DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN GP 120; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOPEPTIDE; NEF PROTEIN; POL PROTEIN; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DRUG CONTROL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; STANDARDIZATION; SWITZERLAND; WORLD HEALTH ORGANIZATION; CONFERENCE PAPER; DEVELOPING COUNTRY; STANDARD; UNITED NATIONS;

AIDS VACCINES; CLINICAL TRIALS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMAN; SWITZERLAND; UNITED NATIONS; WORLD HEALTH ORGANIZATION; HUMANS;

EID: 0037025099     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00028     Document Type: Article

References (8)

1. Recommendations and guidelines for biological substances used in medicine and other documents
2. Preventive HIV type 1 vaccine clinical trials: A regulatory perspective
3. Recombinant bacilus Calmette-Guerin as a potential vector for preventive HIV type 1 vaccines
4. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1. (Report from a meeting of the WHO-UNAIDS Vaccine Advisory Committee, Geneva, 21-23 February 2000)
5. Future access to HIV vaccines. (Report from a WHO-UNAIDS meeting, Geneva, 2-3 October 2000)